Indeed, treatment with IFNγ alone or combined IFNγ and TNFα, but not TNFα alone, sensitized PTPN2- or STUB1-null prostate tumour cells to growth inhibition via measuring the ATP level produced by viable cells (Fig. 5d). Here, IFNG is linked to prostate neoplasm.